BioGaia AB (publ) (STO:BIOG.B)
Sweden · Delayed Price · Currency is SEK 122.10
0.00 (0.00%)
Oct 15, 2026, 1:36 PM CET
BioGaia AB Market Cap
BioGaia AB has a market cap or net worth of 12.35 billion as of October 14, 2026. It is the 9,028th most valuable company in the world and the 116th biggest in Sweden. Its market cap has increased by 16.06% in one year.
Market Cap
12.35B
Enterprise Value
11.91B
Revenue
1.58B
Global Rank
Country Rank
#116 Sweden
PE Ratio
35.60
ChartMarket Cap Chart
Since December 31, 1998, BioGaia AB's market cap has increased from 181.00M to 12.35B, an increase of 6,724.19%. That is a compound annual growth rate of 16.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 12.35B | 14.97% |
| Dec 30, 2025 | 10.74B | -5.09% |
| Dec 30, 2024 | 11.32B | 10.77% |
| Dec 29, 2023 | 10.22B | 21.10% |
| Dec 30, 2022 | 8.44B | -19.33% |
| Dec 30, 2021 | 10.46B | -3.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 152.22B |
| Nanexa AB | 1.95B |
| Cereno Scientific AB | 1.12B |
| Dicot Pharma AB | 856.07M |
| EQL Pharma AB | 659.99M |
| Cinclus Pharma Holding AB | 590.10M |
| Moberg Pharma AB | 535.03M |
| Enzymatica AB | 427.21M |